In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling

Alena Shantsila; Professor Gregory Lip

doi:10.7326/acpj202004210-042

Article2023

Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes

Elaine Ku, Charles E. McCulloch, Lesley A. Inker, Hocine Tighiouart, Franz Schaefer, Elke Wühl, Piero Ruggenenti, Giuseppe Remuzzi, Barbara Grimes, Mark J. Sarnak

Letter2023

Nocturnal BP Profile Predicts CPAP Effect on BP in Patients With OSA and Resistant Hypertension

Martino F. Pengo, Grace Oscullo, José Daniel Gómez-Olivas, Grzegorz Bilo, Gianfranco Parati, Miguel Ángel Martínez‐García

Letter2021

In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies

Ameenathul M. Fawzy, Professor Gregory Lip

Article2021

MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM)

Paul G. Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Cheng Zheng, Franck Dubin, Helgi van de Velde, Kenneth C. Anderson

Article2021

Poster: MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM)

Paul G. Richardson, Aurore Perrot, Jesús F. San Miguel, Meral Beksaç, Ivan Špıčka, Xavier Leleu, Fredrik Schjesvold, Philippe Moreau, Meletios A Dimopoulos, Jeffrey Shang-Yi Huang, Jiří Minařík, Michèle Cavo, H. Miles Prince, Cheng Zheng, Franck Dubin, Helgi van de Velde, Kenneth C. Anderson

In patients with SBP ≥ 130 mm Hg and CV risk, intensive vs standard BP control did not increase fear of falling

Abstract

Discussion(0)

Related publications

Intensive BP Control in Patients with CKD and Risk for Adverse Outcomes

Nocturnal BP Profile Predicts CPAP Effect on BP in Patients With OSA and Resistant Hypertension

In ACS, de-escalation of DAPT reduces bleeding and does not increase ischemic events vs. other DAPT strategies

MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM)

Poster: MM-130: Updates from ICARIA-MM, a Phase 3 Study of Isatuximab (Isa) Plus Pomalidomide and Low-Dose Dexamethasone (Pd) vs Pd in Relapsed and Refractory Multiple Myeloma (RRMM)